NuCana
IPONuCana plc - ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agents
NuCana was founded in 2008, is headquartered in Edinburgh, United Kingdom, lists 11–50 employees, and has $67.3M in recorded funding across 2 rounds.
- Headquarters
- Edinburgh
- Employees
- 11–50
- Founded
- 2008
- Business Model
- B2B
- Website
- nucana.com
- Total Funding
- $67.3M
- Last Round
- $10.3M Extension RoundJun 2025
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
NuCana is a Nasdaq-listed, clinical-stage biopharmaceutical company headquartered in Edinburgh, Scotland, focused on significantly improving treatment outcomes for patients with cancer. Founded in 2008 by CEO Hugh Griffith, the company applies its proprietary ProTide phosphoramidate technology to transform established nucleoside analogs into more effective and safer anti-cancer medicines designed to overcome key cancer resistance mechanisms. NuCana's pipeline includes candidates targeting colorectal, pancreatic, and other cancers, with the ProTide platform enabling much higher concentrations of active anti-cancer metabolites within tumor cells compared to conventional chemotherapy. The company also maintains a U.S. office in Newton, Massachusetts.
Summary
NuCana is a Biotech company based in Edinburgh, United Kingdom, founded in 2008. It lists 11–50 employees. It has raised $67.3M in total across 2 rounds, most recently a $10.3M Extension Round in Jun 2025. Investors include Sofinnova Partners and Alida Capital International.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jun 2025
Sign up to see all 3 events
Funding: Series B through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nucana"><img src="https://indexed.vc/api/badge/company/nucana" alt="NuCana on Indexed.vc" width="260" height="76" /></a>